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Starter Question 
Poll:    www.slido.com     #TheDataDialogue 
 
Have you ever: 
Worked with clinical data? 
Had clinical data recorded from you? 
Benefited from clinical data? 
The processes and benefits of 
sharing clinical data 
P. H. Charlton 
 
Guy’s and St Thomas’ NHS Foundation Trust 
King’s College London 
http://peterhcharlton.github.io/RRest/ Views my own 
Poll:   www.slido.com     #TheDataDialogue 
Respiratory Rate Estimation Project 
Poll:   www.slido.com     #TheDataDialogue 
An alternative approach 
finger probe     heart monitor 
Poll:   www.slido.com     #TheDataDialogue 
Estimating respiratory rate 
finger probe     heart monitor 
Adapted from: 
(1) Addison, P.S. et al.: Developing an algorithm for pulse oximetry derived respiratory rate (RR(oxi)): a healthy volunteer study. Journal of Clinical 
Monitoring and Computing, 26(1), 45-51 (2012), DOI: 10.1007/s10877-011-9332-y ; (2) Pimentel, M.A. et al.: Probabilistic estimation of respiratory rate 
from wearable sensors. in Wearable Electronics Sensors, Springer International Publishing, 15, 241-262 (2015), DOI: 10.1007/978-3-319-18191-2_10 ; and 
(3) Charlton P.H. and Bonnici T. et al. An assessment of algorithms to estimate respiratory rate from the electrocardiogram and photoplethysmogram, 
Physiological Measurement, 37(4), 2016. DOI: 10.1088/0967-3334/37/4/610 
 
Aim 
To assess the performance of algorithms to estimate respiratory 
rate from routinely monitored signals 
reference 
 
 
heart monitor 
 
 
finger probe 
 
Poll:   www.slido.com     #TheDataDialogue 
Secondary aims 
Share … 
 
benchmark dataset 
standardised implementations of algorithms 
 
… for future research 
Poll:   www.slido.com     #TheDataDialogue 
Starter Question 
Poll:    www.slido.com     #TheDataDialogue 
 
Have you ever: 
Worked with clinical data? 
Had clinical data recorded from you? 
Benefited from clinical data? 
The processes and benefits of 
sharing clinical data 
“individually identifiable health 
information” [1]  
patient care or a clinical trial [2] 
Common law duty of confidentiality 
Data Protection Act 1988 [3] 
The processes and benefits of 
sharing clinical data 
Processes 
Setting up a clinical trial 
• Is my study clinical research?  
If so, it must: 
• Comply with the Declaration of Helsinki [1] … 
• … by following Good Clinical Practice [2]  
 
Setting up a clinical trial 
• Is my study clinical research?  
If so, it must: 
• Comply with the Declaration of Helsinki [1] … 
• … by following Good Clinical Practice [2]  
 
This trial: 
• changed patient care and generated generalisable findings 
• was reviewed by ethics committee 
• required informed consent and publication of trial design 
• did not disclose participants’ identities 
 
Preparation to share data 
1. Plan in funding applications  [3]  
 
2. Plan to ask subjects for consent 
• Include details in the information sheet 
• Statement on consent form 
(Consent may not always be required:        ) 
 
 
Clinical trial data must usually be de-identified before sharing: [7]  
• It must not identify an individual 
• There must be no reasonable basis to believe it can be used to identify an 
individual (multiple datasets?) 
 
De-identification 
“The data holder is ultimately responsible for 
ethical and legal obligations” [4]  
De-identification 
Clinical trial data must usually be de-identified before sharing: [7]  
• It must not identify an individual 
• There must be no reasonable basis to believe it can be used to identify an 
individual (multiple datasets?) 
 
Expert Determination Safe Harbor 
Methodology Apply statistical or scientific 
principles 
Removal of 18 types of 
identifiers 
Result Very small risk that 
anticipated recipient could 
identify individual 
No actual knowledge 
residual information can 
identify individual 
Adapted from [7]  
De-identification 
Clinical trial data must usually be de-identified before sharing: [7]  
• It must not identify an individual 
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individual (multiple datasets?) 
 
Expert Determination Safe Harbor 
Methodology Apply statistical or scientific 
principles 
Removal of 18 types of 
identifiers 
Result Very small risk that 
anticipated recipient could 
identify individual 
No actual knowledge 
residual information can 
identify individual 
Adapted from: [7] 
e.g. names, dates (inc. age) 
De-identification 
Clinical trial data must usually be de-identified before sharing: [7]  
• It must not identify an individual 
• There must be no reasonable basis to believe it can be used to identify an 
individual (multiple datasets?) 
 
“it is not possible to ensure that the probability of re-
identification is zero” [8] 
De-identification 
Data collection: 
 
• Subject key 
 
 
• Filenames   RRest001_finger_probe.csv 
    RRest001_heart_monitor.csv 
    RRest001_demographics.csv 
Subject ID Participant 
RRest001 Mark Antony 
RRest002 Marcus Brutus 
RRest003 Julius Caesar 
RRest004 Octavius Caesar 
De-identification 
 
reference 1 
 
reference 2 
 
heart monitor 
 
finger probe 
 
28th July: 12:31:47     12:31:51     12:31:55     12:31:59     12:32:03     12:32:07 
 
Time [HH:MM:SS] 
Subj: RRest001 Gender: Female  Age: 99 
De-identification 
 
reference 1 
 
reference 2 
 
heart monitor 
 
finger probe 
 
28th July: 12:31:47     12:31:51     12:31:55     12:31:59     12:32:03     12:32:07 
 
Time [HH:MM:SS] 
Subj: RRest001 Gender: Female  Age: 99 
Pseudonymous Age > 90 
Dates 
De-identification 
 
reference 1 
 
reference 2 
 
heart monitor 
 
finger probe 
 
0                  4                   8                 12                 16                20 
 
Elapsed Time [s] 
Subj: anon  Gender: Female  Age: Elderly 
Data preparation 
Data prepared for analysis: 
• to reduce workload and domain-specific knowledge requirements 
• whilst retaining all potentially useful information (usually not raw data  [9]) 
 
 
Data preparation 
Data prepared for analysis: 
• to reduce workload and domain-specific knowledge requirements 
• whilst retaining all potentially useful information (usually not raw data  [9]) 
This trial: 
• re-format 
 
 
Milliseconds since 01.01.1970;SpO2-O2(%);Perf-
REL(-);Pulse-Pulse(bpm);NBP-MEAN(mmHg);RR-
RR(rpm);NBP-SYS(mmHg);NBP-DIA(mmHg);PVC-CNT(bpm) 
4102444800000;;;56;;18;;;0 
4102444801025;98.6;2.1;57;;18;;;0 
4102444802050;98.4;2.0;58;;18;;;0 
4102444803075;98.2;2.0;57;;18;;;0 
4102444804100;98.3;2.0;56;;18;;;0 
4102444805125;98.2;1.9;56;;19;;;0 
Data preparation 
Data prepared for analysis: 
• to reduce workload and domain-specific knowledge requirements 
• whilst retaining all potentially useful information 
This trial: 
• re-format 
• time-alignment 
 
Data preparation 
Data prepared for analysis: 
• to reduce workload and domain-specific knowledge requirements 
• whilst retaining all potentially useful information 
This trial: 
• re-format   •    extraction of relevant periods 
• time-alignment 
 
 
Rest 
10 min 
Walk 
2 min 
Run 
~ 5 min 
Recover 
10 min 
Sharing data 
Method: [5],[8] 
 
 
 
 
 
 
Level of security 
Open 
Access 
- - - - - -  C o n t r o l l e d  A c c e s s  - - - - - -  
Probability of re-identification 
Publicly 
available 
Terms of 
Use 
Data 
Analysis Plan 
Full 
Contract 
Sharing data 
The following should be shared: [6] 
 
• Analytic Dataset 
• Metadata 
• Protocol 
• Study Analysis Plan 
• Analysis code 
 
 
 
 
 
 
 
 
Sharing data 
This trial: 
• Data: Open access, accessible format 
• Algorithms: GitHub respository 
Additional Materials 
• User Manual 
– updated as Qs arise 
Additional Materials 
• User Manual 
– updated as Qs arise 
• Tutorial 
Adapted from: [1] 
Additional Materials 
• User Manual 
– updated as Qs arise 
• Tutorial 
• Instructions for replicating analyses 
Replicating this Publication 
The work presented in this case study can be replicated as follows: 
• Download data from the MIMIC II dataset using the script provided here. 
• Use Version 1 of the toolbox of algorithms. To perform the analysis call the 
main script using the following command: RRest('mimicii') 
Compatability 
• Other datasets take a variety of formats 
• They can be imported using the scripts provided 
Toolbox 
Benefits 
This project 
• Transparency 
• Reproducibility 
• Internal peer review 
• Ongoing peer review 
• Required by some journals [14] and funding providers 
Future benefits 
• Build on our work 
• More accessible to non-specialists 
• Multiple dataset studies 
• Promoting collaboration 
• Increase speed of research 
• New research questions 
• Decreased burden on research subjects 
• Education of students 
Conclusions 
• Considered the processes for collection and sharing of clinical 
trial data, using the Respiratory Rate Estimation project as a 
case study. 
• Looked briefly at the benefits of sharing clinical data 
• Links are provided to references and additional resources 
This presentation is part of the Respiratory Rate Estimation Project at: 
http://peterhcharlton.github.io/RRest/  
Acknowledgments 
The views expressed are those of the author and not necessarily those of Guy’s and St Thomas’ 
NHS Foundation Trust, King’s College London, the EPSRC, NHS, NIHR, Department of Health, 
Wellcome Trust, or Royal Academy of Engineering. 
Clinical   Engineering  Funders 
Dr Tim Bonnici  Prof David Clifton  EPSRC 
Prof Richard Beale  Prof Lionel Tarassenko NIHR 
Dr Peter Watkinson  Dr Mauricio Villarroel Wellcome Trust 
John Brooks  Dr Marco Pimentel  Royal Academey of Engineering 
Isabelle Schelcher  Dr Christina Orphanidou 
Ricky Yang 
Katie Lei 
John Smith 
Additional Acknowledgments 
Thanks also to: 
• Jason Long for Cayman Theme which inspired this presentation template 
• Open Clipart for some of the images in this presentation 
References 
Additional details of the Vortal Study, which formed part of the case study in 
this presentation, are available in the following publication: 
 
Charlton P.H. and Bonnici T. et al. An assessment of algorithms to estimate 
respiratory rate from the electrocardiogram and photoplethysmogram, 
Physiological Measurement, 37(4), 2016. DOI: 10.1088/0967-3334/37/4/610 
 
References 
[1]  World Medical Association, 2013. World Medical Association Declaration of Helsinki: 
Ethical Principles for Medical Research Involving Human Subjects. JAMA, 310(20), pp.E1 – 
E4. DOI: 10.1001/jama.2013.281053 
  Foundational principles for clinical research 
[2]  ICH Expert Working Group, 1996. Guideline for Good Clinical Practice. Link 
  A standard for ensuring the ethical quality of trials involving human 
 subjects. Consistent with the principles in the Declaration of Helsinki. 
[3]  Veerle Van den Eynden et al., 2011. Managing and Sharing Data - Best Practice For 
Researchers. UK Data Archive, pp.1–40. Link 
  Helpful ‘how to’ for managing and sharing data, including: writing a  data 
 management and sharing plan (p.6) 
 
References 
[4]  Tucker, K. et al., 2016. Protecting patient privacy when sharing patient-level data from 
clinical trials. BMC Medical Research Methodology, 16(S1), p.77. DOI: 10.1186/s12874-016-
0169-4 
  Recommends data anonymisation and controlled access to shared data, with 
 suggestions of practical methods for each process. 
[5]  Smith, C. et al., 2015. Good practice principles for sharing individual participant data from 
publicly funded clinical trials. Trials, 16(Suppl 2). DOI: 10.1186/1745-6215-16-S2-O1 
  Helpful advice on sharing data from clinical trials, including: data sharing 
 models (p.9); handling data requests (p.13); text for use in a consent form 
 (p.16); an example Data Use Agreement (p.22). 
[6]  Institute of Medicine, 2015. Sharing Clinical Trial Data: Maximizing Benefits, Minimizing 
Risk, Washington, D.C.: National Academies Press. DOI: 10.17226/18998 
  Essential reading – perhaps the most useful resource to date on sharing 
 clinical trial data. 
 
References 
[7]  HHS (U.S. Department of Health and Human Services), 2012. Guidance regarding methods 
for de-identification of protected health information in accordance with the Health Insur- 
ance Portability and Accountability Act (HIPAA) Privacy Rule. Link – accessed on 26th July 
2016. 
   Detailed guidance on exactly how to de-identify data. A helpful introduction 
 is provided in [4]. 
[8]  Emam, K. El et al., 2015. Anonymising and sharing individual patient data. The BMJ, 350, 
p.h1139. DOI: 10.1136/bmj.h1139  
  Brief overview of “key concepts and principles for anonymising health data 
 while ensuring it remains suitable for meaningful analysis”. 
[9]  Lo, B., 2015. Sharing Clinical Trial Data. JAMA, 313(8), p.793. DOI: 10.1001/jama.2015.292. 
  A commentary by the Chair of the committee who contributed to the report 
 in [6]. Considers the question of whether to share raw data. 
References 
[10]  Rosenblatt, M., Jain, S.H. & Cahill, M., 2015. Sharing of Clinical Trial Data: Benefits, Risks, 
and Uniform Principles. Annals of Internal Medicine, 162(4), p.306. DOI: 10.7326/M14-
1299    
[11]  Goodman, S.N., 2015. Clinical trial data sharing: What do we do now? Annals of Internal 
Medicine, 162(4), pp.308–309. DOI: 10.7326/M15-0021   
[12]  Mello, M.M. et al., 2013. Preparing for Responsible Sharing of Clinical Trial Data. New 
England Journal of Medicine, 369(17), pp.1651–1658. DOI: 10.1056/NEJMhle1309073 
[13]  Drazen, J.M., 2015. Sharing Individual Patient Data from Clinical Trials. New England 
Journal of Medicine, 372(3), pp.201–202. DOI: 10.1056/NEJMp1415160 
[14]  Taichman, D.B. et al., 2016. Sharing Clinical Trial Data — A Proposal from the International 
Committee of Medical Journal Editors. New England Journal of Medicine, 374(4), pp.384–
386. DOI: 10.1056/NEJMe1515172 
[15]  Sandercock, P.A. et al., 2011. The International Stroke Trial database. Trials, 12, p.101. DOI: 
10.1186/1745-6215-12-101 
Additional Resources 
Is my study clinical research? 
A study is clinical research if it involves:  
• Randomised treatments, or  
• Changing treatment / patient care from accepted standards, or  
• Generalisable findings  
 
For further information, and to check whether your study is classed 
as clinical research, see the tool at: 
http://www.hra-decisiontools.org.uk/research/ 
 
 
Obtaining consent to share data 
Include information in the patient information sheet, and a 
statement in the informed consent form, such as the following text 
(as suggested by the Health Research Authority): 
 
“I understand that the information collected about me will be used 
to support other research in the future, and may be shared 
anonymously with other researchers.” 
 
These details are taken from [5], p.16 
Is consent required? 
 
 
 
 
 
 
 
Usually anonymisation is a must. Even then, check with local 
authorities (e.g. Healthcare provider, Ethics Committee)  
“The best way … is to 
obtain consent” [5] 
“A lack of consent for 
sharing should not 
prohibit sharing … 
anonymised data” [5] 
“Sharing of data without specific 
participant consent may be ethically 
acceptable and legally permitted in 
certain instances.” [6] 
“Many jurisdictions … do not designate 
anonymised health data as personal 
information. Therefore, such data would no 
longer be covered by privacy laws.” [8] 
Is consent required? A case study 
The International Stroke Trial Database reported in did not require 
consent specifically for data sharing: 
 
When creating this database, “consent for publication of raw data 
was not obtained from participants”. Whilst consent for participation 
in the trial was obtained, the patients “were treated 15-20 years ago, 
and many have died. The dataset is fully anonymous … In our view, 
publication of the dataset clearly presents no material risk to 
confidentiality of study participants.” [15] 
 
How to share data 
The UK Data Archive have suggested several ways of sharing data [3]: 
 
• Data repository 
• Supplementary material in a journal publication 
• Intitutional repository 
• Project or institutional website 
• Informal sharing with peers 
 
For further details see p.4 of [3] 
Benefits of sharing data 
Several benefits of sharing clinical data are mentioned in the literature, such as: 
• Providing new insights [10] 
• Clarifying the effectiveness and safety of medicines [10] 
• Preventing repetition of data collection and research [10] 
• Improving transparency [10] 
• Improving public trust in research [10] 
• Improved meta-analyses [11] 
• Real-world examples for teaching [11] 
• Speed up innovation [12] 
• Reward risk of trial participants [13] 
Several concerns are also mentioned in the literature, such as: 
• Potential for misleading analyses of trial data [10] 
• De-identification of trial participants [10] 
